Myeloma Treatment Debates: Key CoMy 2026 Controversies and Clinical Decisions with Mohamad Mohty

In this CoMy 2026 discussion, Mohamad Mohty breaks down the biggest controversies in myeloma treatment, from transplant and CAR-T to bispecific antibodies and real-world clinical decisions. Get expert insights into the debates shaping the future of multiple myeloma care. If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/6286... For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer! Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_so... Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.

Is There a Cure for Myeloma? How Long Will I Live?  Dr. Sundar Jagannath on Why Cure is Within Reach
▶︎

Is There a Cure for Myeloma? How Long Will I Live? Dr. Sundar Jagannath on Why Cure is Within Reach

The Immune System in Myeloma: How It Shapes Treatment and Outcomes
▶︎

The Immune System in Myeloma: How It Shapes Treatment and Outcomes

Understanding Your Myeloma Labs: What They Mean, What Matters, and When to Ask Questions
▶︎

Understanding Your Myeloma Labs: What They Mean, What Matters, and When to Ask Questions

Can We Prevent Taste Loss with Talquetamab? TALISMAN Study Brings New Hope | EHA 2026
▶︎

Can We Prevent Taste Loss with Talquetamab? TALISMAN Study Brings New Hope | EHA 2026

Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained
▶︎

Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained

Expert Tips for Managing Myeloma Side Effects & Improving Immunity | Elizabeth O’Donnell, MD
▶︎

Expert Tips for Managing Myeloma Side Effects & Improving Immunity | Elizabeth O’Donnell, MD

10 Hidden Social Rules in Germany Nobody Warns You About!
▶︎

10 Hidden Social Rules in Germany Nobody Warns You About!

Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t
▶︎

Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t

Top 10 Multiple Myeloma Breakthroughs from ASH 2025 | CAR-T & Bispecific Antibodies Explained
▶︎

Top 10 Multiple Myeloma Breakthroughs from ASH 2025 | CAR-T & Bispecific Antibodies Explained

Optimizing Bispecific Therapy in Myeloma: Choosing the Right Time for Treatment | EHA 2026
▶︎

Optimizing Bispecific Therapy in Myeloma: Choosing the Right Time for Treatment | EHA 2026

Beyond One-Size-Fits-All: Martin Kaiser on Precision Diagnostics in Multiple Myeloma | EHA 2026
▶︎

Beyond One-Size-Fits-All: Martin Kaiser on Precision Diagnostics in Multiple Myeloma | EHA 2026

What Happens After CAR T-Cell Therapy? Myeloma Experts Answer Common Questions
▶︎

What Happens After CAR T-Cell Therapy? Myeloma Experts Answer Common Questions

Anitocabtagene autoleucel achieves deep and durable responses in relapsed/refractory multiple mye...
▶︎

Anitocabtagene autoleucel achieves deep and durable responses in relapsed/refractory multiple mye...

Real-World Treatment Sequencing After CAR-T vs Bispecific Antibodies in Multiple Myeloma | EHA 2026
▶︎

Real-World Treatment Sequencing After CAR-T vs Bispecific Antibodies in Multiple Myeloma | EHA 2026

Interpreting MGUS/Smoldering Myeloma Labs- What To Know and When To Take Action
▶︎

Interpreting MGUS/Smoldering Myeloma Labs- What To Know and When To Take Action

CAR-T Without the Wait: Reprogramming T-cells Inside Your Body for Myeloma | EHA 2026
▶︎

CAR-T Without the Wait: Reprogramming T-cells Inside Your Body for Myeloma | EHA 2026

Is Multiple Myeloma Fatal? What Experts Say About Living a Normal Life
▶︎

Is Multiple Myeloma Fatal? What Experts Say About Living a Normal Life

Talquetamab Steps Forward: MonumenTAL-3 - A New Potential for GPRC5D Therapy in Myeloma | EHA 2026
▶︎

Talquetamab Steps Forward: MonumenTAL-3 - A New Potential for GPRC5D Therapy in Myeloma | EHA 2026

Exciting Clinical Trials for CLL in 2025
▶︎

Exciting Clinical Trials for CLL in 2025

Smoldering Myeloma: What We Know and Where We're Going
▶︎

Smoldering Myeloma: What We Know and Where We're Going